Biohaven Ltd. (BHVN)
(Delayed Data from NYSE)
$36.90 USD
-0.02 (-0.05%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $36.87 -0.03 (-0.08%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -1.71 |
EPS Last Quarter | -3.64 |
Last EPS Surprise | -111.63% |
ABR | 1.07 |
Earnings ESP
|
0.77% |
---|---|
Current Year | -8.92 |
Next Year | -6.75 |
EPS (TTM) | -9.15 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 100.00M | 100.00M | 33.10M |
# of Estimates | NA | 1 | 1 | 3 |
High Estimate | NA | 100.00M | 100.00M | 50.00M |
Low Estimate | NA | 100.00M | 100.00M | 9.59M |
Year ago Sales | 0.00M | 0.00M | NA | 100.00M |
Year over Year Growth Est. | NA | NA | NA | -66.90% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.71 | -1.60 | -8.92 | -6.75 |
# of Estimates | 7 | 5 | 8 | 7 |
Most Recent Consensus | -1.80 | -1.86 | -9.30 | NA |
High Estimate | -1.30 | -0.44 | -7.79 | -5.66 |
Low Estimate | -2.02 | -2.15 | -10.15 | -8.55 |
Year ago EPS | -1.50 | -1.81 | -5.73 | -8.92 |
Year over Year Growth Est. | -14.00% | 11.60% | -55.67% | 24.32% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 2 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 3 | 4 | 6 | 2 |
Down Last 60 Days | 2 | 3 | 5 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.71 | -1.60 | -8.92 | -6.75 |
7 Days Ago | -1.71 | -1.60 | -8.92 | -6.75 |
30 Days Ago | -1.66 | -1.52 | -7.29 | -6.82 |
60 Days Ago | -1.71 | -1.52 | -7.40 | -6.92 |
90 Days Ago | -1.71 | -1.52 | -7.40 | -6.92 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.69 | -1.51 | -9.05 | -6.79 |
Zacks Consensus Estimate | -1.71 | -1.60 | -8.92 | -6.75 |
Earnings ESP | 0.77% | 5.35% | -1.44% | -0.58% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -3.64 | -2.20 | -1.81 | -1.50 | NA |
Estimate | -1.72 | -1.50 | -1.41 | -1.33 | NA |
Difference | -1.92 | -0.70 | -0.40 | -0.17 | -0.80 |
Surprise | -111.63% | -46.67% | -28.37% | -12.78% | -49.86% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more